US HB2565 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 70-45)
Status: Introduced on April 15 2021 - 25% progression, died in committee
Action: 2021-04-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 15 2021 - 25% progression, died in committee
Action: 2021-04-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a drug, and for other purposes.
Title
FDA Modernization Act of 2021
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2021-04-16 | House | Referred to the Subcommittee on Health. |
| 2021-04-15 | House | Referred to the House Committee on Energy and Commerce. |
| 2021-04-15 | House | Introduced in House |
Same As/Similar To
HB7667 (Related) 2022-06-09 - Received in the Senate.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/2565/all-info |
| Text | https://www.congress.gov/117/bills/hr2565/BILLS-117hr2565ih.pdf |
